Header Logo

Connection

Kyle Amber to Skin Diseases, Vesiculobullous

This is a "connection" page, showing publications Kyle Amber has written about Skin Diseases, Vesiculobullous.
Connection Strength

4.879
  1. Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibition. J Eur Acad Dermatol Venereol. 2023 11; 37(11):e1339-e1340.
    View in: PubMed
    Score: 0.857
  2. Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review. Int J Dermatol. 2020 May; 59(5):520-524.
    View in: PubMed
    Score: 0.662
  3. Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548.
    View in: PubMed
    Score: 0.615
  4. Gastrointestinal prophylaxis in patients with autoimmune blistering disease treated with corticosteroids: an expert survey. Int J Dermatol. 2018 11; 57(11):e125-e126.
    View in: PubMed
    Score: 0.610
  5. Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers. JAMA Dermatol. 2017 11 01; 153(11):1189-1190.
    View in: PubMed
    Score: 0.578
  6. Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis. JAMA Dermatol. 2017 11 01; 153(11):1137-1141.
    View in: PubMed
    Score: 0.578
  7. Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United States. J Am Acad Dermatol. 2015 Aug; 73(2):337-8.
    View in: PubMed
    Score: 0.494
  8. A Systematic Review of Patients with Mucocutaneous and Respiratory Complications in Paraneoplastic Autoimmune Multiorgan Syndrome: Castleman's Disease is the Predominant Malignancy. Lung. 2015 Aug; 193(4):593-6.
    View in: PubMed
    Score: 0.485
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.